High throughput physicochemical profiling for drug discovery

Journal of Pharmaceutical Sciences

Volumn 90, Issue 11, 2001, Pages 1838-1858

  Kerns, Edward H ^a  

^a PFIZER INC   (United States)

Author keywords

Discovery; High throughput; Methods; Physicochemical; Profiling

Indexed keywords

ACETAZOLAMIDE; ADIPIODONE; ALLOPURINOL; BENDROFLUMETHIAZIDE; BENZOCAINE; BENZTHIAZIDE; BETAMETHASONE; BUTYL PARABEN; BUTYLCAINE; CHLORPROPAMIDE; CLOFAZIMINE; DRUG; FLURBIPROFEN; GEMFIBROZIL; HYDROCORTISONE; HYDROFLUMETHIAZIDE; HYDROQUININE; MORIN; NITROFURAL; OXYPHENBUTAZONE; PHENACEMIDE; PHENYLBUTAZONE; PREDNISONE; PROGESTERONE; PROPYL PARABEN; THEOBROMINE; TOLAZAMIDE; TRIMETHOPRIM; TYROSINE; UNINDEXED DRUG;

CAPILLARY ELECTROPHORESIS; CHROMATOGRAPHY; DRUG PENETRATION; DRUG RESEARCH; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; LIPOPHILICITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; NEPHELOMETRY; PH; PHYSICAL CHEMISTRY; PKA; POTENTIOMETRY; PRODUCTIVITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVIEW; TECHNOLOGY; TURBIDIMETRY; ULTRAFILTRATION; ULTRAVIOLET RADIATION;

EID: 0035150465     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.1134     Document Type: Review

References (82)

1. LC/MS Applications in Drug Development
2. Pharmaceutical innovation by the seven U.K.-owned pharmaceutical companies (1964-1985)
3. Role of the Development Scientist in Compound Lead Selection and Optimization
4. Drug selection in early drug development: Screening for acceptable pharmacokinetic properties using combined in vitro and computational approaches
5. High throughput drug metabolism
6. Gastrointestinal absorption of drugs: Methods and studies
7. Compound optimization in early- and late-phase drug development: Acceptable pharmacokinetic properties utilizing combined physicochemical, in vitro and in vivo screens
8. Absorption prediction from physicochemical parameters
9. A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
10. The fundamental variables of the biopharmaceutics classification system (BCS): A commentary
11. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting
12. Computational and experimental approaches to avoiding solubility and oral absorption problems in early discovery
13. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates
14. High throughput aqueous drug solubility by laser nephelometry
15. Evaluation of in vitro precipitation methods
16. Validation of solubility measurements using ultra-filtration liquid chromatography mass spectrometry (UF-LC/MS)
17. High throughput measurements of solubility profiles
18. Human intestinal permeability
19. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters
20. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond
21. Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption
22. pH-Metric logP 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs
23. IAM chromatography: An in vitro screen for predicting drug membrane permeability
24. Immobilized-artificial membrane chromatography: Measurements of membrane partition coefficient and predicting drug membrane permeability
25. Immobilized artificial membranes-screens for drug membrane interactions
26. Membrane partition coefficients chromatographically measured using immobilized artificial membrane surfaces
27. Predicting Drug-Membrane Interactions by HPLC: Structural requirements of chromatographic surfaces
28. Use of Immobilized Artificial Membrane Chromatography for Drug Transport Applications
29. Comparison of the retention behavior of β-blockers using immobilized artificial membrane chromatography and lysophospholipid micellar electrokinetic chromatography
30. Evaluation of the immobilized artificial membrane phosphatidylcholine drug discovery column for high-performance liquid chromatographic screening for drug-membrane interactions
31. Immobilized liposome and biomembrane partitioning chromatography of drugs for prediction of drug transport
32. Rapid-gradient HPLC method for measuring drug interactions with immobilized artificial membrane: Comparison with other lipophilicity measures
33. Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes
34. Structure and electrochemical properties of microfiltration filter-lipid systems
35. Permeation of drug through a model membrane consisting of Millipore filter with oil
36. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes
37. PH-metric log P: II: Refinement of partition coefficients and ionization constants of multiprotic substances
38. Automated pKa determination at low solute concentrations by capillary electrophoresis
39. Capillary zone electrophoresis for the determination of dissociation constants
40. Investigation of experimental approaches to the determination of pKa values by capillary electrophoresis
41. Determination of dissociation constants of cytokinins by capillary zone electrophoresis
42. Determination of absolute mobilities, pK values and separation numbers by capillary zone electrophoresis. Effective mobility as a parameter for screening
43. Capillary zone electrophoresis in mixed aqueous-organic media: Effect of organic solvents on actual ion mobilities and acidity constants of substituted aromatic acids III. 1-propanol
44. Determination of dissociation constants of cephalosporins by capillary zone electrophoresis
45. Affinity capillary electrophoresis in pharmaceutics
46. Rapid physicochemical profiling as an aid to drug candidate selection
47. Methods for determining n-octanol-water partitioning constants
48. Octanol-water partition: Searching for predictive models
49. A method for measuring 1-octanol-water partition coefficients
50. Partitioning of ionized molecules between aqueous buffers and phospholipid vesicles
51. Reevaluating equilibrium and kinetic binding parameters from lipophilic drugs based on a structural model for drug interaction with biological membranes
52. High throughput log D determination using parallel liquid chromatography/mass spectrometry
53. Rapid physicochemical profiling as an aid to drug discovery and development
54. Buffer effects on partitioning of organic compounds in octanol-buffer systems: Lipophilicity in drug disposition
55. Automated workstation for octanol-buffer measurements in physicochemical screening
56. PH-Metric log P. 4. Comparison of partition coefficients determined by HPLC and potentiometric methods to literature values
57. A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography
58. Development of a preformulation lipophilicity screen utilizing a C-18-derivatized polystyrene-divinylbenzene high-performance liquid chromatographic (HPLC) column
59. Exploratory chemometric analysis of the classification of pharmaceutical substances based on chromatographic data
60. Measurement and prediction of hydrophobicity parameters for highly lipophilic compounds: Application of the HPLC column-switching technique to measurement of log P of diarylpyrazines
61. Connection between chromatographic data and biological data
62. Chromatographic hydrophobicity index by fast-gradient RPHPLC: A high-throughput alternative to log P/log D
63. Relationships between the chromatographic hydrophobicity indices and solute descriptors obtained by using several reversed-phase, diol, nitrile, cyclodextrin and immobilized artificial membrane-bonded high-performance liquid chromatography columns
64. Rapid gradient RP-HPLC method for lipophilicity determination: A solvation equation based comparison with isocratic methods
65. Rapid Method for the Estimation of Octanol/Water Partition Coefficient (Log Poct) from Gradient RP-HPLC Retention and a Hydrogen Bond Acidity Term
66. oct: A tool for lipophilicity determination in drug discovery
67. Scales of solute hydrogen-bonding: Their construction and application to physicochemical and biomedical processes
68. Determination of solute lipophilicity, as log P(octanol) and log P(alkane) using poly(styrene-divinylbenzene) and immobilised artificial membrane stationary phases in reversed-phase high performance liquid chromatography
69. Structural properties governing retention mechanisms on RP-HPLC stationary phases used for lipophilicity measurements
70. Phosphatidylcholine-coated silica as a useful stationary phase for high-performance liquid chromatographic determination of partition coefficients between octanol and water
71. ow) by microemulsion electrokinetic chromatography
72. Hydrogen bonding XXXV
73. Automated analytical systems for drug development studies. I. A system for the determination of drug stability
74. Electrochemistry/thermospray/tandem mass spectrometry in the study of biooxidation of purines
75. In vitro mimicry of metabolic oxidation reactions by electrochemistry/mass spectrometry
76. Predictive strategy for the rapid structure elucidation of drug degradants
77. High throughput stability profiling for drug discovery
78. Property-based design: Optimization of drug absorption and pharmacokinetics